At least 21 prescription drug groups have been associated with increased fracture risk.
1-12 The list includes some of the most commonly used products in the United States, such as opioids, proton pump inhibitors (PPIs), serotonin reuptake inhibitors (SSRIs), and sedatives.
13 The wide use of many fracture-associated drugs (FADs) suggests that concurrent receipt of 2 or more may be prevalent. This in turn raises concern for fracture risk associated with such exposure. Logic suggests that risk will increase with the addition of each additional FAD. However, the fracture risk of such combined drug use has not been quantified. Understanding the prevalence of concurrent FAD exposure and its risk is especially important to older people, who have the highest baseline rate of fragility fracture and who are most likely to receive multiple FADs as diagnoses and treatments accumulate with age.